Track topics on Twitter Track topics that are important to you
9-19Shimo Shinjo 3-chome, Higashi Yodogawa-ku
Phone: 81 6 6321 7045
Fax: 81 6 6325 8209
PeptiDream Inc. and Santen Pharmaceutical Co. Ltd. are teaming up in the discovery and development of ophthalmic compounds.
Santen has started the Phase III SPECTRUM trial of omidenepag isopropyl (DE-117) 0.002% against timolol maleate 0.5% for the treatment...Read More... The post Santen starts Phase III trial of DE-117 a...
Sharp will provide secondary packaging services for Santen’s ophthalmic products
PeptiDream Inc., a public Kanagawa-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) announced today that it has entered into a broad-based multi-target discovery and...
SanBio Co., Ltd. and US subsidiary SanBio, Inc. conducted the following personnel transfers, effective October 1, 2018. 1. Transfer DetailsAkihiro Tsujimura will become a...
Santen Pharmaceutical Co Ltd 4536 Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compile...
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 31 July 2018 - 7:00am (CET) Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major sha...
Famotidine Tablets, USP 20 mg
Facility Maintenance Instant Hand Sanitizer HS-67
To prioritize occupational hazards in a Pharmaceutical Company in Iran using the analytical hierarchy process (AHP).
Within (European) healthcare systems, the predominant goal for pharmaceutical expenditure is cost containment. This is due to a general belief among healthcare policy makers that pharmaceutical expend...
Although excipients are pharmacologically inert substances, still they are integral and significant ingredients of a pharmaceutical formulation. Their amount and concentration level along with the act...
Santen will evaluate the intraocular pressure (IOP) lowering effect and efficacy of DE-117 ophthalmic solution 0.002% in latanoprost/non-responder subjects diagnosed with POAG or OHT
To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...
The implementation of pharmaceutical consultations in the city or at the hospital could modify the occurrence of exacerbations related to chronic obstructive pulmonary disease after return...
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.
This study compared the relative bioavailability (rate and extent of absorption) of Pravastatin Sodium Tablets 80 mg by Teva Pharmaceutical Industries, Ltd. with that of Pravachol® Tablet...
Since its foundation in 1890, Santen Pharmaceutical Co., Ltd. has contributed to the protection and improvement of people's eyesight and health. Santen's integrated operations extend from research and...
As a specialty company dedicated to the ophthalmic and anti-rheumatic fields, Santen carries out the research, development, sales, and marketing of pharmaceuticals. The company ha...
Santen Inc., based in Emeryville, California, is the U.S. subsidiary of Santen Pharmaceutical Co., Ltd., a billion-dollar global company headquartered in Osaka, Japan since 1890. ...
Santen Inc. is responsible for the development and commercialization of eye care pharmaceuticals in the U.S. It also serves as the international headquarters for Santen's business in Europe, with resp...
We have published hundreds of Santen Pharmaceutical Company Limited news stories on BioPortfolio along with dozens of Santen Pharmaceutical Company Limited Clinical Trials and PubMed Articles about Santen Pharmaceutical Company Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Santen Pharmaceutical Company Limited Companies in our database. You can also find out about relevant Santen Pharmaceutical Company Limited Drugs and Medications on this site too.